July 24, 2014Zecotek Display Systems and the Institute of Chemical Physics Develop Metal Alloys for 3D Printing
March 29, 2011Joint Institute for Nuclear Research for CERN COMPASS Experiment to Use Solid-State Photo Detectors
February 10, 2010Prestigious University to use Zecotek's LFS Crystals for Next-Generation PET Program
April 15, 2009Zecotek Establishes Ongoing Relationship with CERN with Initial Order of MAPD photo detectors
March 03, 2009Zecotek Closes Financing and Receives Grant Money from the Gov't of Malaysia and Singapore
December 03, 2007Demonstration of 32 inch 3D Display and Insight Media to Advise with 3D Market Entry
Archive of News Releases
To access a complete listing of Zecotek's news releases click here: ...more
$2,300,000 Raised Through Warrants and Options
November 21, 2007
Zecotek Raises Additional $2,300,000
Vancouver, BC – November 21, 2007 - Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt- W1I.F) is pleased to announced that it has raised an additional $2,300,000 from the exercise of share purchase warrants and options in the first and second quarter of fiscal 2008. The Company has now raised an aggregate of $4.8 million through the $2.5 million non-brokered private placement completed in September 2007 and through the exercise of warrants and options since August 1, 2007.Net proceeds from the funds raised will be used for working capital purposes and for projects presently underway at its Singapore operating facilities. The projects include; finalizing the commercial production of the Zecotek’s solid-state MAPD photo-detector, addressing growing requests for the Company’s fiber and solid-state lasers, initiating commercial scale production of the Company’s high performance RFO vanadate laser crystals and establishing a strategic manufacturing and distribution partnership for the Company’s 3D display system.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For additional information please contact:
Zecotek Medical Systems, Inc.
MICHAEL MINDER, CFO; VP Corporate Development, T: (604) 827-5203
Caliber Capital Partners
TIM MCNULTY, T: (778) 327-6678, E: [email protected]
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.